Endothelial Effects of Basal Insulin: Detemir Versus Glargine
NCT00699686
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Endothelial Dysfunction
Cardiovascular Disease
Interventions
DRUG:
Glargine
DRUG:
Detemir
Sponsor
University of Padova